|
|
 |
|
Viewing report
|
|
|
|
Allergan, Inc. (AGN) - Product Pipeline Analysis
GlobalData, May 2011, Pages: 45
Allergan, Inc. (AGN) - Product Pipeline Analysis
Summary
Allergan, Inc. (Allergan) is a global healthcare company engaged in the development and commercialization of products catering to the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, neurological, obesity intervention and other specialty markets. It develops and commercializes innovative pharmaceuticals, biologics and medical devices and over-the-counter products. The company operates through two reportable segments, namely, Specialty Pharmaceuticals and Medical Devices. Its flagship franchises in eye care, neuromodulator, skin care and urologics are structured under its pharmaceutical business portfolio, Allergan Pharmaceuticals. The acquisition of Inamed Corporation resulted in the addition of breast aesthetics and dermal fillers to its business portfolio, comprising a part of Allergan Medical division. The company’s products are sold and distributed in more than 100 countries around the world. Allergan is headquartered in California, the US.
This report is a source for data, analysis and actionable intelligence on the Allergan, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Customers who bought this item also bought
Serica Technologies, Inc. - Product Pipeline Analysis
Allergan, Inc. - Product Pipeline Review - H2 2011
Healthpoint Biotherapeutics - Product Pipeline Analysis
Allergan, Inc. (AGN) - Financial and Strategic SWOT Analysis Review
SafeStitch Medical, Inc. (SFES) - Product Pipeline Analysis
Angiotech Pharmaceuticals, Inc. (ANP) - Product Pipeline Analysis
Palomar Medical Technologies, Inc. (PMTI) - Product Pipeline Analysis
Q-Med AB (QMED) - Product Pipeline Analysis
Mentor Worldwide LLC - Product Pipeline Analysis
Allergan, Inc. - Product Pipeline Review - Q4 2010
|
|
|
|
